Research snapshot · 7/8/26

BIOBio-Rad Laboratories

WATCH

Conviction●○○○○1 of 5

Research target$320.61Snapshot target

Thesis statusNEEDS_MORE_DATALast reviewed 7/8/26

Market cap$7.94BSnapshot value

Research history

What changed

Jul 11, 2026

Target
— → $320.61

Jul 11, 2026

Last reviewed
Not reviewed → 7/8/26

Jul 8, 2026

Target
— → $320.61

The thesis

Instruments + reagents + clinical diagnostics. Digital PCR/qPCR franchise creates recurring consumable pull. Consumables-heavy revenue mix.

Catalysts

PCR/clinical diagnostics volume growth; biopharma R&D spending; consumables pull-through from installed base.

What breaks it

Competitive pressure in PCR from Thermo/QIAGEN; academic budget sensitivity; slower growth profile vs peers.

Social sentiment

needs X/Reddit sentiment sweep

Snapshot · 7/8/26

Smart money

🟢 Confirmed · ins-$0.3M · 13F 17+/7- · short↓0.28

Snapshot · 7/8/26